Colourant and pigment consolidation across Medical Solutions

CRM · Identified

5 agents · last run 01:22 todayDraft outreach

$4.1Mestimated value

2/5roles covered

31sources behind the signal

Identifiedstage

Highrelevance · ranked 1 of 29

Overview Signals3 People2 Win Kit

Why this exists

This puts a competitor-held position in play for the first time in four years.

The chain

what produced this, and what it still needs

1 · Signal

Trelleborg faces an EU REACH restriction that puts two product lines out of compliance by 2027

Pressure Points · 13 sources High confidence

Open signal →

2 · Opportunity

Scored 1 of 29 surfaced · $4.1M

Above the relevance bar 182 scored, 29 surfaced

you are here

3 · People

2 of 5 roles mapped

Missing: Qualifies itFind who qualifies it →

4 · Draft

Not started

Win Kit is ready — 3 proof points and a competitive counter.

Draft outreach →

Win Kit

in your licence

Value hypothesis

Qualification time is the binding constraint, not price.

Proof points

01Qualified at an adjacent site in 11 weeks
02Meets the 2027 restriction threshold today
03Existing MSA removes commercial negotiation from the path

Competitive counter

Incumbent is Freudenberg; their grade does not clear the new limit.

Commercial angle

Lead with a paid trial to compress the qualification decision.

Buying group

2 of 5 roles covered

Runs it

Yuki LindgrenProduction ManagerTrelleborgFit Low

y•••••@trelleborg.com

Funds it

Sofia DelacroixFinancial AnalystWuxiFit High

s•••••@trelleborg.com

Qualifies it

Nobody mapped · R&D

Map the group →

Buys it